Cuvposa FDA Approval History
FDA Approved: Yes (First approved July 28, 2010)
Brand name: Cuvposa
Generic name: glycopyrrolate
Dosage form: Oral Solution
Company: Shionogi Pharma Inc.
Treatment for: Chronic Drooling in Children
Cuvposa (glycopyrrolate) oral solution is an anticholinergic for the treatment of chronic severe drooling caused by neurologic disorders in children.
Development Timeline for Cuvposa
|Jul 29, 2010||FDA Approves Cuvposa for Chronic Drooling in Children|
|Sep 29, 2009||Sciele Pharma Submits New Drug Application to FDA for Glycopyrrolate Oral Solution, a Treatment for Chronic, Moderate-to-Severe Drooling in Pediatric Patients|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.